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1 
ABSTRACT 
 
Fetal neuroinflammation and prenatal stress (PS) may contribute to lifelong neurological           
disabilities. Astrocytes and microglia play a pivotal role, but the mechanisms are poorly             
understood. Here, we test the hypothesis that via gene-environment interactions, fetal           
neuroinflammation and PS may reprogram glial immunometabolic phenotypes which impact          
neurodevelopment and neurobehavior. This glial-neuronal interplay increases the risk for clinical           
manifestation of autism spectrum disorder (ASD) in at-risk children. Drawing on genomic data             
from the recently published series of ovine and rodent glial transcriptome analyses with fetuses              
exposed to neuroinflammation or PS, we conducted a secondary analysis against the Simons             
Foundation Autism Research Initiative (SFARI) Gene database. We confirmed 21 gene hits.            
Using unsupervised statistical network analysis, we then identified six clusters of probable            
protein-protein interactions mapping onto the immunometabolic and stress response networks          
and epigenetic memory. These findings support our hypothesis. We discuss the implications for             
ASD etiology, early detection, and novel therapeutic approaches. 
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A body of preclinical and epidemiological evidence shows that ​in utero exposure to             
infection or stress results in altered neurodevelopmental trajectories including psychiatric          
conditions such as autism spectrum disorder (ASD).​(1)​(2,3)  
However, the mechanisms explaining the individual risk and framework for early            
detection have remained elusive. To explore the potential connections between fetal           
neuroinflammation, prenatal stress (PS) and ASD, and to generate new hypotheses on the             
microglial and astrocytes’ contribution, the key players of brain inflammation, we tested for the              
presence of disruptive mutations to genes involved in pathways associated with stress or             
inflammatory responses in a large sample of children with ASD. We based this method on the                
notion of a multi-species approach to uncovering the etiology of neurodevelopmental           
disorders.​(2) Combining biomarkers derived from observations in multiple species such as           
rodent, ovine and human in the present case, should increase the likelihood of identifying              
translationally valid disease etiology.  
 
Based on the studies in the above-mentioned multiple species, we identified genes            
associated with inflammatory, stress and metabolic phenotype of microglia and astrocytes           
(Table 1). We included genes involved in energy homeostasis based on the observations linking              
neuroimmune and metabolic memory signatures in fetal microglia exposed to LPS and the             
larger emerging gestalt of physiological stress response in immunometabolism, in particular by            
astrocytes.​(4,5) Based on our observations in fetal microglia ​(6,7)​, the simplistic hypothesis is            
that exposure to endotoxin or chronic stress augments energy conservation - driving pathways             
and the α7 nicotinic acetylcholine receptor α7nAChR agonism reduces that response. Such            
gene-environment adaptations should be reflected in changes of epigenetic memory mediated           
by HDAC/HAT networks involved in microglial memory of inflammation.​(6) 
We included the iron homeostasis genes based on the recently postulated interaction            
between this signaling network and the α7nAChR modulation of immunometabolic phenotype of            
fetal microglia.​(7) 
We included the complement pathway genes expressed in microglia and known to be             
modulated by neuroinflammation in microglia and to play an important role in            
neurodevelopmental synaptic pruning.​(7,8) 
Assuming that ​in utero inflammation or stress increase risk for ASD, we hypothesized to              
identify some genes linked to the ASD diagnosis to fall into the family of signaling pathways                
identified in Table 1. We tested that hypothesis statistically against the Simons Foundation             
Autism Research Initiative (SFARI) Gene database.​(9) The SFARI Gene is an evolving online             
database for the autism research community that is centered on genes implicated in autism              
susceptibility.  
 
Table 1. Genes implicated in the signature of astrocytes and microglia exposed to             
endotoxin or maternal stress 
Groups Genes Reference 
Glial cell 
phenotype 
TMEM119 Transmembrane protein 119; identifies resident microglia      (from blood-derived macrophages) ​(10,11) 
3 
TGFβ [4] Transforming growth factor beta-1; resident microglial      biomarker ​(12,13) 
CD11b Resident microglial biomarker ​(11–13) 
CD11c Activated microglia ​(12,13) 
CD45 [4] Protein Tyrosine Phosphatase Receptor Type C (PTPRC);       Resident microglial biomarker ​(11–13) 
Iba1  Ionized calcium binding adaptor molecule 1: Non-specific       microglial / macrophage biomarker ​(6,11–14) 
CX3CR1 [4] CX3C chemokine receptor 1; required for synaptic pruning        during brain development ​(15) 
BRD4 [4] 
Bromodomain containing 4; polarizes microglia toward      
inflammatory phenotype ​(16)​; involved in epigenetic memory       
(17) 
SLC1A2 [S] Astrocytic GLT-1 transporter required for neuron-astrocyte      communication and astrocyte maturation ​(18) 
Inflammation 
HMGB1 
Hypermobility group box protein 1, a pleiotropic signaling        
molecule in glia cells and neurons: a growth factor, a          
pro-inflammatory molecule ​(19)​; implicated in ASD ​(20) 
IL-10 Key regulator of neuroimmune homeostasis via cross-talk of        microglia and astrocytes ​(21) 
IL-6 [5] Early inflammatory cytokine 
NLRP3 Inflammasome activated in ASD ​(22) 
Stress 
CRH [5] 
Corticotropin-releasing hormone, key hormone linking chronic 
stress with anxiety ​(23,24)​; has direct effects on microglia 
(25) 
CRHR2 [5] Corticotropin-releasing hormone receptor 2; ​(25) 
HSD11B1 [4] 11β-Hydroxysteroid dehydrogenase type 1 ​(26) 
POMC Proopiomelanocortin ​(27) 
p-Akt Phosphorylated-Akt ​(28) 
PI3K [S] PI3K/Akt signaling pathway; e.g. PIK3CA ​(28,29) 
OGT [5] 
O-GlcNAc transferase; a placental biomarker of maternal 
stress exposure related to neurodevelopmental outcomes 
(30,31) 
GAP43 [5] 
Growth associated protein 43; in astrocytes, GAP43 mediates        
glial and neuronal plasticity during astrogliosis and attenuates        
microglial activation under LPS exposure ​(32) 
SLC22A3 [5] Solute carrier family 22 member 3; modulates anxiety and         social interaction ​(33,34) 
PLPPR4 [5] Phospholipid Phosphatase Related 4; stress-related     behaviors such as reduced resilience ​(35) 
PRKCB [3] Protein Kinase C Beta; involved in stress-related behavior        (36) 
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UCN3 [5] Urocortin 3; binds specifically CRHR2 ​(25) 
DLG4 [5] Disks large homolog 4; modulates stress reactivity and        anxiety ​(37,38) 
Energy 
homeostasis 
Cx43 Connexin 43 gap junction maintaining astrocytes’      homeostasis via metabolic cooperation ​(39) 
AMPK Adenosine monophosphate kinase, intracellular energy     sensor​(40) 
FBP Fructo-biphosphokinase: signature of second-hit memory of      inflammation in fetal microglia ​(6) 
mTOR [S] Mammalian target of the rapamycin signaling pathway       (41,42) 
Iron 
homeostasis 
HAMP 
Hepcidin, a regulator of iron homeostasis and inflammation;        
implicated, along with ferroportin and transferrin, in microglial        
response to endotoxin interfering with α7nAChR signaling ​(7) 
SLC40A1 Ferroportin gene 
TFR2 Transferrin receptor 2;  involved in iron sequestration 
TFRC Transferrin receptor protein 1; needed for iron sequestration 
HMOX1 
Hemoxygenase 1, key enzyme of iron homeostasis also        
serves as a signature of second-hit memory in fetal microglia          
and promoted by α7nAChR agonism ​(6,43) 
SLC25A39​ ​[4] Member of the SLC25 transporter or mitochondrial carrier        family of proteins; required for normal heme biosynthesis 
Complement 
pathway 
C1QA Aside from its traditional role in innate immunity ​(44)​,         
elements of the complement pathway are involved in        
neuronal-glial interactions; recognized as essential players in       
brain development, especially in synaptogenesis/synaptic     
pruning and predisposition for neurodegenerative diseases      
(8,45)​, their microglial expression is also susceptible to LPS         
exposure ​in utero ​(7) 
C1QB 
C​(7)​3AR1 
CR2 
C4B [4] 
Epigenetic 
memory 
HDAC [S]​ and 
HAT​ families 
Histone acetylation/deacetylation enzymes: HDAC 1, 2, 3, 7        
and 9 found in SSC database of ASD gene mutations. 
HDAC 1, 2, ​4 and 6 involved in fetal microglial memory of            
LPS exposure; HDAC 1, 2, ​4 and 7 ​increased with altered           
neuronal AChE signaling and increased anxiety behavior due        
to adult chronic stress exposure ​(6,7,27,29,46,47) 
Hits in the SFARI database ​(9)​ are in bold. ASD association score ​(48)​ indicated in square 
brackets: S: syndromic; 1: high confidence; 2: strong candidate; 3: suggestive evidence; 4: 
minimal evidence; 5: hypothesized; 6: not supported. 
 
We used that database to identify genes with varying degrees of disruptive mutations             
associated with ASD as defined in the SFARI database to any of the genes in Table 1. The                  
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analysis is based on accessing the database in August 2019 corresponding to the SFARI              
database update of June 20, 2019. 
We identified 21 hits indicated in Table 1 in bold along with the level of confidence for                 
association with ASD using the SFARI scoring criteria.​(48) Scores denoted as S identified             
syndromic category and lower numbers in the range from 1 to 6 mean higher confidence in the                 
association, 1 being the highest and 6 being the lowest. It is apparent that all categories defined                 
in Table 1 are represented in the SFARI database: microglial or astrocytic phenotype,             
inflammation, stress, energy homeostasis, iron homeostasis, complement pathway, and         
epigenetic memory.  
Next, we sought to validate the significance of the association of the identified genes              
using network analysis with string-db.org. The results can be accessed online at the ​permanent              
URL​. They represent the analysis of the subset of 21 genes identified in Table 1. While                
individually 16 out of the 21 identified genes were scored as weakly associated with ASD               
(scores 4 or 5 denoting minimal evidence or hypothesized), the network analysis shows a              
significant interaction between all 21 nods on the protein-protein interaction level with six             
network clusters shown in Figure 1. These clusters form stress, metabolism, glia phenotype and              
epigenetic memory aspects of the proposed neuro-immunometabolic network exposed to stress           
or inflammation. 
 
The data summarized in Figure 1 support our initial hypothesis linking both            
neuroinflammation and stress exposures ​in utero to etiology of ASD in a gene-environment             
paradigm: developmental combinations of genetic alterations in key pathways susceptible to           
environmental stimuli of inflammation or stress increase risk for or, perhaps, cause ASD. The              
clusters of interactions map onto the neuro-immunometabolic and stress response networks.  
Current estimates suggest that variation in as many as 1,000 different genes could affect              
susceptibility to autism. In the attempt to tie this wealth of data together conceptually in a unified                 
model, an endophenotype of autism has been proposed.​(49) It is defined as a predictive              
impairment. Sinha ​et al. note in ​(49) that providing a cohesive conceptualization of ASD, such               
as the predictive impairment endophenotype, would ameliorate the search for broadly effective            
therapies, diagnostic markers, and neural/genetic correlates. Indeed, setting the ASD on the            
information theoretical platform in terms of prediction impairment reveals links to a major             
disruptor of the neural information processing - the stress. For example, the prediction             
impairment hypothesis interprets the reduced habituation and hence greater stress in ASD            
subjects as being caused by an endogenous predictive impairment which leads the            
environmental stimuli to appear more chaotic. By the same token, an autistic individual             
responds to the chaotic-appearing environment with endogenous mechanisms geared to          
reducing the chaos by exhibiting ritualized behaviors. These features of the proposed ASD             
endophenotype all have in common an attempt to reduce stress arising from increased             
uncertainty. Peters ​et al. ​provide a neurobiological perspective on these psychological           
observations.​(50) Their observations are based on the well-founded physical-mathematical         
concepts linking the energy expenditure, entropy and information processing, going back to            
Shannon and Boltzmann.​(51,52) This is combined with a body of neurobiological literature on             
the neuronal substrate of the brain’s stress and prediction networks.​(50) Herein, the so-called             
6 
Selfish Bayesian Brain resolves stress, or information uncertainty, by an internal Baysian update             
of the knowledge state. This must take place at the expense of transiently increased energy               
needs (hence “selfish”). If this update succeeds, the stress is eustress; if it doesn’t, it becomes a                 
distress. The present findings suggest that one possible mechanism for when such an update              
can fail is when the increased energy needs cannot be met. We are proposing a developmental                
origins perspective on this framework. The neuro-immunometabolic and stress response          
networks interact and ​in utero exposure to stress or inflammation may alter the glial              
immunometabolic phenotype, i.e., the pattern of this network interaction. That consequence           
translates into less energy availability under the increased demands due to stress.​(50) If the              
energy needs are not met, the allostatic load turns into an allostatic overload.​(53)             
Neuropathology may ensure unless the situation is corrected. 
We hope these data can be used in future ​in vivo ​studies to probe mechanistically for the                 
role of these immunometabolic gene and protein networks in ASD etiology, in particular in the               
areas described as being the core of the prediction processing network, the anterior cingulate              
cortex.​(54,55) Indeed, a recent study reported that an immunometabolic dysregulation reduces           
the thickness of the anterior cingulate cortex.​(56)  
The therapeutic approaches may include early postnatal reprogramming of the effects           
the intrauterine stress or inflammation exerted on brain development using behavioral (e.g.,            
environmental enrichment) or bioelectronic tools.​(57)  
In the context of the discussed neuro-immunometabolic and Selfish Bayesian Brain           
paradigms, environmental enrichment may help reduce the allostatic load by providing           
opportunities to perform the required knowledge state update in the face of existing             
uncertainties, i.e., stress.  
Other salutary mechanisms mediating the therapeutic approaches may involve activation          
of the afferent cholinergic pathway. Vagal afferent signaling affects widely distributed areas of             
the brain via Nucleus tractus solitarii, and studies indicate that stimulation of the vagus nerve               
activates many neurons in both cerebral hemispheres and hippocampus.​(58,59) Vagal signaling           
in near-term fetus decreases HMGB1 concentrations in neuronal and astrocyte cytoplasm           
expressing α7nAChR and decreases microglial activation, which may decrease glial          
priming.​(14) Hence, efferent peripheral or afferent vagal activity may mediate central           
neuroprotection via regulation of neuroinflammation. Vagus nerve stimulation has been shown           
to alter the phase synchrony in the anterior cingulate cortex improving decision making in              
rats.​(60) 
The efferent wiring of the vagal cholinergic pathway has begun to unravel in the last               
decade, while our understanding of the afferent signaling is only beginning to emerge. The              
efferent component is also referred to as the inflammatory reflex which acts via the cholinergic               
anti-inflammatory pathway (CAP), a neural mechanism that influences the magnitude of innate            
immune responses to inflammatory stimuli and maintains homeostasis.​(62) Through CAP,          
increased vagal activity inhibits the release of pro-inflammatory cytokines. We found that            
spontaneous CAP activity is present in the sheep fetus as early as at 0.76 gestation.​(63)               
Moreover, CAP activation near-term suppresses activation of ovine microglia and astrocytes           
which express α7 nAChR or hypoxic-ischemic brain damage in newborn rats.​(14,19,64–67)  
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Figure 1. Gene network analysis of ASD associated genes driven by exposure to stress or inflammation                
followed by Markov Cluster Algorithm for unsupervised clustering identifies significant interactions           
between six clusters containing microglial and astrocytic phenotypes, inflammation, stress, energy (but            
not iron) homeostasis, and complement pathway. Note that stress pathways are represented in four              
clusters (yellow, green, aquamarine, dark cyan), while microglial phenotype, inflammation and           
complement pathway comprise one cluster (red). Protein-protein interaction (PPI) enrichment p-value:           
0.00085. PPI legend by string-db.org ​(61) The detailed list of participating node members is provided in                
the Supplementary Table S1. 
 
In summary, these data suggest that early behavioral therapy or enhancing fetal CAP             
activity via vagal nerve stimulation or α7nAChR agonists will suppress the activation of microglia              
and astrocytes restoring their physiological immunometabolic phenotype, thus decreasing glial          
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priming and preventing a sustained switch to a reactive phenotype. This approach might             
decrease the degree of brain injury sustained from fetal systemic and brain inflammatory             
responses and stress exposures, thus improving postnatal short- and long-term health           
outcomes, including susceptibility to ASD. 
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